Tusamitamab Ravtansine

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
BPS-82934-1	1 mg	-	-	-	3 - 8 business days*		2,253.00€
BPS-82934-2	5 mg	-	-	-	3 - 8 business days*		5,966.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5,... more

Close menu

Product information "Tusamitamab Ravtansine"

Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 , via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.81,2,3.

Keywords:	Anti-CEA, Anti-CD66e, Anti-Meconium antigen 100, Anti-Carcinoembryonic antigen, Anti-CEA cell adhesion molecule 5, Anti-Cell adhesion molecule CEACAM5, Anti-Carcinoembryonic antigen-related cell adhesion molecule 5,
Supplier:	BPS Bioscience
Supplier-Nr:	82934

Properties

Application:	Cancer therapy target studies
Antibody Type:	Monoclonal
Conjugate:	No
Species reactivity:	human
MW:	~148 kD
Format:	Solution

Database Information

CAS :	2254086-60-5\| Matching products
KEGG ID :	K06499 \| Matching products
UniProt ID :	P06731 \| Matching products
Gene ID :	GeneID 1048 \| Matching products

Handling & Safety

Storage:	-80°C (protect from light)
Shipping:	-80°C (International: -80°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 82934 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Tusamitamab Ravtansine"

Write a review